The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Open accessAbstract
SUMMARY Clusters of circulating tumor cells (CTC-clusters) are present in the blood of patients with cancer but their contribution to metastasis is not well defined. Using mouse models with tagged mammary tumors, we demonstrate that CTC-clusters arise from oligoclonal tumor cell groupings and not from intravascular aggregation events. Although rare in the circulation compared with single CTCs, CTC-clusters have 23-50-fold increased metastatic potential. In patients with breast cancer, single-cell resolution RNA sequencing of CTC-clusters and single CTCs, matched within individual blood samples, identifies the cell junction component plakoglobin as highly differentially expressed. In mouse models, knockdown of plakoglobin abrogates CTC-cluster formation and suppresses lung metastases. In breast cancer patients, both abundance of CTC-clusters and high tumor plakoglobin levels denote adverse outcomes. Thus, CTC-clusters are derived from multicellular groupings of primary tumor cells held together through plakoglobin-dependent intercellular adhesion, and while rare, they greatly contribute to the metastatic spread of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 2×
“…School, Boston, MA 02129, USA 7Department of Surgery, Harvard Medical School, Boston, MA 02129, USA 8Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA *Correspondence: dhaber@mgh.harvard.edu (D.A.H.), maheswaran@helix.mgh.harvard.edu (S.M.) http://dx.doi.org/10.1016/j.cell.2014.07.013”
BackgroundInfluentialDEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Wang, L., Feng, Z., Wang, X., Wang, X., & Zhang, X. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp612 · Cited by 4,553
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Self-citationGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712
Cited by
Items 101–131 of 131
Roles for E-cadherin cell surface regulation in cancer
Petrova, Y. I., Schecterson, L., & Gumbiner, B. M. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0058 · Cited by 275
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Nishida, A., & Andoh, A. (2025) · Cells · doi:10.3390/cells14070488 · Cited by 270
Jia, D., Park, J., Jung, K., Levine, H., & Kaipparettu, B. (2018) · Cells · doi:10.3390/cells7030021 · Cited by 270
Park, M.-H., Reátegui, E., Li, W., Tessier, S. N., Wong, K. H. K., Jensen, A. E., Thapar, V., Ting, D., Toner, M., Stott, S. L., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12236 · Cited by 267
Self-citationLiquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Russano, M., Napolitano, A., Ribelli, G., Iuliani, M., Simonetti, S., Citarella, F., Pantano, F., Dell’Aquila, E., Anesi, C., Silvestris, N., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01601-2 · Cited by 260
Better together: circulating tumor cell clustering in metastatic cancer
Schuster, E., Taftaf, R., Reduzzi, C., Albert, M. K., Romero-Calvo, I., & Liu, H. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.07.001 · Cited by 260
EMT: Present and future in clinical oncology
Santamaria, P. G., Moreno‐Bueno, G., Portillo, F., & Cano, A. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12091 · Cited by 259
Taftaf, R., Liu, X., Singh, S., Jia, Y., Dashzeveg, N. K., Hoffmann, A. D., El-Shennawy, L., Ramos, E. K., Adorno-Cruz, V., Schuster, E. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25189-z · Cited by 261
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
Cañellas-Socias, A., Cortina, C., Hernando-Momblona, X., Palomo-Ponce, S., Mulholland, E. J., Turon, G., Mateo, L., Conti, S., Roman, O., Sevillano, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05402-9 · Cited by 256
Fang, J., Zhou, H., Zhang, C., Shang, L., Zhang, L., Xu, J., Zheng, L., Yuan, Y., Guo, R., Jia, W., et al. (2015) · Hepatology · doi:10.1002/hep.27760 · Cited by 256
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Murlidhar, V., Reddy, R. M., Fouladdel, S., Zhao, L., Ishikawa, M. K., Grabauskiene, S., Zhang, Z., Lin, J., Chang, A. C., Carrott, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2072 · Cited by 181
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
Celià-Terrassa, T., & Jolly, M. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036905 · Cited by 163
A review of microfluidic approaches for investigating cancer extravasation during metastasis
Ma, Y.-H. V., Middleton, K., You, L., & Sun, Y. (2018) · Microsystems & Nanoengineering · doi:10.1038/micronano.2017.104 · Cited by 154
van Staalduinen, J., Baker, D., ten Dijke, P., & van Dam, H. (2018) · Oncogene · doi:10.1038/s41388-018-0378-x · Cited by 158
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Gaggar, S., & Gögenur, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668731 · Cited by 150
Comaills, V., Kabeche, L., Morris, R., Buisson, R., Yu, M., Madden, M. W., LiCausi, J. A., Boukhali, M., Tajima, K., Pan, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.022 · Cited by 124
Self-citationCirculating Tumor Cells: Fluid Surrogates of Solid Tumors
Thiele, J.-A., Bethel, K., Králíčková, M., & Kuhn, P. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100256 · Cited by 107
Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
Wen, X., Pu, H., Liu, Q., Guo, Z., & Luo, D. (2022) · Cancers · doi:10.3390/cancers14246025 · Cited by 99
Bhagwat, N., Dulmage, K., Pletcher, C. H., Wang, L., DeMuth, W., Sen, M., Balli, D., Yee, S. S., Sa, S., Tong, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23217-5 · Cited by 75
An integrated microfluidic device for rapid and high-sensitivity analysis of circulating tumor cells
Jiang, J., Zhao, H., Shu, W., Tian, J., Huang, Y., Song, Y., Wang, R., Li, E., Slamon, D., Hou, D., et al. (2017) · Scientific Reports · doi:10.1038/srep42612 · Cited by 66
Kurzeder, C., Nguyen-Sträuli, B. D., Krol, I., Ring, A., Castro-Giner, F., Nüesch, M., Asawa, S., Zhang, Y. W., Budinjas, S., Gvozdenovic, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03486-6 · Cited by 64
Self-citationAnalyzing Circulating Tumor Cells One at a Time
Ortiz, V., & Yu, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.004 · Cited by 48
Self-citationVelez, D. O., Ranamukhaarachchi, S. K., Kumar, A., Modi, R. N., Lim, E. W., Engler, A. J., Metallo, C. M., & Fraley, S. I. (2019) · Integrative Biology · doi:10.1093/intbio/zyz019 · Cited by 45
Hu, B., Xin, Y., Hu, G., Li, K., & Tan, Y. (2023) · APL Bioengineering · doi:10.1063/5.0156628 · Cited by 36
Peters, N. A., Constantinides, A., Ubink, I., van Kuik, J., Bloemendal, H. J., van Dodewaard, J. M., Brink, M. A., Schwartz, T. P., Lolkema, M. P. J. K., Lacle, M. M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.969855 · Cited by 35
The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights
Joshi, V. B., Gutierrez Ruiz, O. L., & Razidlo, G. L. (2023) · Cancers · doi:10.3390/cancers15072169 · Cited by 32
Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma
Yoshino, H., Tatarano, S., Tamai, M., Tsuruda, M., Iizasa, S., Arima, J., Kawakami, I., Fukumoto, W., Kawahara, I., Li, G., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.056 · Cited by 24
Liao, C.-J., Hsieh, C.-H., Wang, H.-M., Chou, W.-P., Chiu, T.-K., Chang, J.-H., Chao, A.-C., & Wu, M.-H. (2017) · RSC Advances · doi:10.1039/c7ra03663a · Cited by 20
Resource allocation in mammalian systems
Baghdassarian, H. M., & Lewis, N. E. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108305 · Cited by 17
Metadata
- Authors
- Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., Brannigan, B. W., Kapur, R., Stott, S. L., Shioda, T., Ramaswamy, S., Ting, D. T., Lin, C. P., Toner, M., Haber, D. A., & Maheswaran, S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 158
- Issue
- 5
- Pages
- 1110-1122
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1993913242
- Cited by
- 2,441
- References
- 52
- FWCI
- 70.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.